Autoantibody biomarkers for the early detection of ovarian cancer

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12196757
APP PUB NO 20220163531A1
SERIAL NO

17563279

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BRIGHAM AND WOMEN'S HOSPITAL INC75 FRANCIS STREET BOSTON MA 02115

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, Karen Scottsdale, US 36 223
Cramer, Daniel Chestnut Hill, US 6 50
Katchman, Benjamin Tempe, US 16 54
LaBaer, Joshua Chandler, US 72 1244
Wallstrom, Garrick Mesa, US 17 116

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 14, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 14, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 14, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00